GSK (GSK) Short Interest Ratio & Short Volume → The only accurate crypto trading system I know … (From Weiss Ratings) (Ad) Free GSK Stock Alerts $40.88 -0.36 (-0.87%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media GSK Short Interest DataCurrent Short Volume4,830,000 sharesPrevious Short Volume3,970,000 sharesChange Vs. Previous Month+21.66%Dollar Volume Sold Short$207.06 millionShort Interest Ratio / Days to Cover1.4Last Record DateMarch 31, 2024Outstanding Shares2,072,440,000 sharesFloat Size2,030,000,000 sharesShort Percent of Float0.24%Today's Trading Volume1,816,110 sharesAverage Trading Volume3,448,385 sharesToday's Volume Vs. Average53% Short Selling GSK ? Sign up to receive the latest short interest report for GSK and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGSK Short Interest Over TimeGSK Days to Cover Over TimeGSK Percentage of Float Shorted Over Time Ad Weiss RatingsThe only accurate crypto trading system I know …Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.Here's what our expert says you should buy before April 14. GSK Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20244,830,000 shares $207.06 million +21.7%0.2%1.4 $42.87 3/15/20243,970,000 shares $167.49 million -16.6%0.2%1.1 $42.19 2/29/20244,760,000 shares $199.40 million +3.0%0.2%1.3 $41.89 2/15/20244,620,000 shares $193.02 million +40.4%0.2%1.3 $41.78 1/31/20243,290,000 shares $129.74 million +18.4%0.2%1 $39.44 1/15/20242,780,000 shares $111.48 million +1.5%0.1%0.9 $40.10 Get the Latest News and Ratings for GSK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. 12/31/20232,740,000 shares $101.54 million -6.2%0.1%0.9 $37.06 12/15/20232,920,000 shares $104.76 million +5.4%0.1%0.9 $35.88 11/30/20232,770,000 shares $99.71 million -25.9%0.1%0.8 $36.00 11/15/20233,740,000 shares $128.92 million -6.5%0.2%1 $34.47 10/31/20234,000,000 shares $142.80 million -17.4%0.2%1.1 $35.70 10/15/20234,840,000 shares $177.53 million -8.2%0.2%1.4 $36.68 9/30/20235,270,000 shares $191.04 million -5.4%0.3%1.6 $36.25 9/15/20235,570,000 shares $208.46 million +14.9%0.3%1.7 $37.43 8/31/20234,850,000 shares $170.48 million -7.8%0.2%1.4 $35.15 8/15/20235,260,000 shares $185.47 million +6.1%0.3%1.6 $35.26 7/31/20234,960,000 shares $176.43 million +1.6%0.2%1.6 $35.57 7/15/20234,880,000 shares $168.51 million +3.8%0.2%1.6 $34.53 6/30/20234,700,000 shares $167.51 million +22.4%0.2%1.5 $35.64 6/15/20233,840,000 shares $135.44 million +15.3%0.2%1.3 $35.27 5/31/20233,330,000 shares $111.89 million -10.5%0.2%1.2 $33.60 5/15/20233,720,000 shares $136.82 million -5.8%0.2%1.3 $36.78 4/30/20233,950,000 shares $142.32 million +16.2%0.2%1.2 $36.03 4/15/20233,400,000 shares $128.42 million +4.0%0.2%1 $37.77 3/31/20233,270,000 shares $116.35 million -14.8%0.2%0.9 $35.58 3/15/20233,840,000 shares $128.95 million +33.3%0.2%1 $33.58 2/28/20232,880,000 shares $98.70 million -23.0%0.1%0.6 $34.27 2/15/20233,740,000 shares $133.03 million -50.5%0.2%0.8 $35.57 1/31/20237,550,000 shares $266.21 million +0.7%0.4%1.5 $35.26 1/15/20237,500,000 shares $265.35 million -11.0%0.4%1.4 $35.38 12/30/20228,430,000 shares $296.23 million -22.8%0.4%1.5 $35.14 12/15/202210,920,000 shares $389.08 million -5.3%0.5%1.7 $35.63 11/30/202211,530,000 shares $398.82 million +2.5%0.6%1.7 $34.59 11/15/202211,250,000 shares $363.26 million -15.8%0.6%1.8 $32.29 10/31/202213,360,000 shares $443.15 million -15.8%0.7%1.8 $33.17 10/15/202215,870,000 shares $487.37 million +0.3%0.8%2.3 $30.71 9/30/202215,830,000 shares $465.88 million +13.3%0.8%2.3 $29.43 9/15/202213,970,000 shares $433.35 million +10.0%0.7%2.2 $31.02 8/31/202212,700,000 shares $412.50 million +49.1%0.6%2.1 $32.48 8/15/20228,520,000 shares $297.77 million +39.2%0.4%1.5 $34.95The only accurate crypto trading system I know … (Ad)Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.Here's what our expert says you should buy before April 14. GSK Short Interest - Frequently Asked Questions What is GSK's current short interest? Short interest is the volume of GSK shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 4,830,000 shares of GSK short. 0.24% of GSK's shares are currently sold short. Learn More on GSK's current short interest. What is a good short interest ratio for GSK? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GSK shares currently have a short interest ratio of 1.0. Learn More on GSK's short interest ratio. Which institutional investors are shorting GSK? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GSK: IMC Chicago LLC, Optiver Holding B.V., IMC Chicago LLC, Wells Fargo & Company MN, Genus Capital Management Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for GSK? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.24% of GSK's floating shares are currently sold short. Is GSK's short interest increasing or decreasing? GSK saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 4,830,000 shares, an increase of 21.7% from the previous total of 3,970,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is GSK's float size? GSK currently has issued a total of 2,072,440,000 shares. Some of GSK's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GSK currently has a public float of 2,030,000,000 shares. How does GSK's short interest compare to its competitors? 0.24% of GSK's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to GSK: Regeneron Pharmaceuticals, Inc. (1.29%), Bristol-Myers Squibb (1.73%), Zoetis Inc. (0.80%), Vertex Pharmaceuticals Incorporated (1.55%), Sanofi (0.16%), Takeda Pharmaceutical Company Limited (0.26%), Pfizer Inc. (1.15%), Abbott Laboratories (0.84%), Novartis AG (0.21%), AstraZeneca PLC (0.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short GSK stock? Short selling GSK is an investing strategy that aims to generate trading profit from GSK as its price is falling. GSK shares are trading down $0.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GSK? A short squeeze for GSK occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GSK, which in turn drives the price of the stock up even further. How often is GSK's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GSK, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Regeneron Pharmaceuticals Short Squeeze Bristol-Myers Squibb Short Squeeze Zoetis Short Squeeze Vertex Pharmaceuticals Short Squeeze Sanofi Short Squeeze Takeda Pharmaceutical Short Squeeze Pfizer Short Squeeze Abbott Laboratories Short Squeeze Novartis Short Squeeze AstraZeneca Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:GSK) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry